Fish oils for the secondary prevention of coronary heart disease
Report for the Complementary Healthcare Council of Australia
Coronary heart disease (CHD) affects more Australians than any other single disease – and accounts for nearly one fifth of all deaths. This study, for the Complementary Healthcare Council of Australia, was undertaken to establish a cost benefit analysis of the use of fish oil supplements as a complementary treatment for coronary heart disease, stroke and myocardial infarction (MI). It is founded on the links established by well-documented epidemiological studies between the consumption of fatty fish (such as mackerel, herrings, sardines, salmon and tuna) and lower incidence rates of these diseases.
The study estimates the net benefit (cost) of using fish oils alongside primary treatment for the prevention of heart disease among those Australians who have experienced MI, versus its non-use, using World Health Organisation guidelines for benchmarking cost effectiveness. It concludes that the use of fish oil supplements is a cost effective intervention to address cardiovascular mortality and morbidity in Australia.
The report is structured as follows:
Section 1: Background
Section 2: Methodology: indication, intervention, comparator, effectiveness, benefits, costs, cost effectiveness model
Section 3: Results: cost effectiveness findings, population-wide applications, cost benefit analysis